— Know what they know.
Not Investment Advice
Also trades as: GBM.F (FSX) · $vol 0M · GBMB.F (FSX) · $vol 0M

INO Short Interest

Inovio Pharmaceuticals, Inc.
1W: -11.9% 1M: -23.9% 3M: -14.4% YTD: -47.3% 1Y: -61.8% 3Y: -84.2% 5Y: -99.0%
$0.89
+0.02 (+2.32%)
Pre-Market: $0.92 (+0.03, +3.92%)
Weekly Expected Move ±15.4%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 26 · $61.5M mcap · 82M float · 4.45% daily turnover · Short 31% of daily vol
Credit Risk of going bust: higher than 80% of companies Debt: 11.5% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the third-riskiest tenth, about 1 in 140 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.02 (down 98%), Inovio Pharmaceuticals, Inc. would be worth roughly what it owes.
Total debt $8.0M against a stock market value of $61.5M.
Distance to default 2.60 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $4.0M (short-term plus half of long-term), stock volatility 98.2%; Altman Z'' -130.58. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Short Volume Summary

2026-10-26
35.6%
Short Ratio
of total volume
38.0%
20-Day Avg
35.8%
50-Day Avg
▼ Falling
5-Day Trend
0.6M
Short Volume
1.7M
Total Volume

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

2026-10-26
ExchangeShort VolumeTotal VolumeShort %
NASDAQ 592,741 1,603,896 37.0%
NYSE 16,209 106,860 15.2%
BATS 896 3,598 24.9%

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms